GAD 65 (Glutamic Acid Decarboxylase ) Antibodies

Description

GAD 65 (Glutamic Acid Decarboxylase) Antibodies Test detects antibodies targeting the GAD enzyme, which is involved in neurotransmitter production. This test is primarily used in diagnosing autoimmune forms of diabetes, particularly latent autoimmune diabetes in adults (LADA) and type 1 diabetes. It’s also valuable in identifying certain neurological disorders. The presence of these antibodies can indicate an ongoing autoimmune process and help predict the risk of developing type 1 diabetes in at-risk individuals. This test is crucial for early diagnosis and appropriate management of autoimmune diabetes and related conditions.